{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:07:44Z","timestamp":1788847664096,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"\n Background<\/jats:title>\n Mobile health applications may support self-management in inflammatory bowel diseases (IBD), but evidence on first-use experiences with disease-specific mobile health applications is limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To evaluate first-use usability of the noncommercial MyTARGET mobile application among adults with IBD in Germany and identify priorities for refinement.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In this single-center cross-sectional usability survey, adults with Crohn's disease or ulcerative colitis installed MyTARGET on their own smartphones, received a 15-minute standardized introduction and independently explored the application for 45\u2005min during one outpatient session. Participants completed a 13-item questionnaire adapted from the German Telehealth Usability Questionnaire on a 7-point Likert scale. Recommendation intention was assessed using the Net Promoter Score (NPS).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n All 200 participants completed the questionnaire (mean age 39.1 years; SD, 14.0; 48.0% female); 127\/200 (63.5%) had Crohn's disease and 73\/200 (36.5%) had ulcerative colitis. Mean overall usability was 6.00 (SD, 0.57; 95% CI, 5.92\u20136.08). User-friendliness (mean, 6.65; SD, 0.61) and ease of learning (mean, 6.41; SD, 0.59) received the highest ratings, whereas error handling\/troubleshooting (mean, 5.59; SD, 0.93) and perceived time savings were lower. The Net Promoter Score was +16 points. Overall usability correlated with recommendation score (Spearman\n \u03c1<\/jats:italic>\n \u2009=\u20090.606; adjusted\n p<\/jats:italic>\n \u2009&lt;\u20090.001) and usefulness, interface quality and satisfaction\/intention to use again showed stronger associations than user-friendliness.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n MyTARGET showed high patient-reported first-use usability in this selected outpatient sample. The findings identify aspects that could inform future refinement and suggest that ease of use alone may not determine willingness to recommend an IBD app.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fdgth.2026.1957062","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:35:04Z","timestamp":1788845704000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported first-use usability of the noncommercial MyTARGET mobile application among adults with inflammatory bowel disease: a cross-sectional survey"],"prefix":"10.3389","volume":"8","author":[{"given":"Daria","family":"Vasilyeva-Singer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine 1, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Rath","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Kretzschmar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Knitza","sequence":"additional","affiliation":[{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]},{"name":"Department of Internal Medicine 3, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"AGEIS, Universit\u00e9 Grenoble Alpes","place":["Grenoble, France"]},{"name":"Institute for Digital Medicine, University Hospitals of Giessen and Marburg, Philipps University of Marburg","place":["Marburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Atreya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Orlemann","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine 1, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-N\u00fcrnberg","place":["Erlangen, Germany"]},{"name":"German Center for Immunotherapy, Friedrich-Alexander University Erlangen-N\u00fcrnberg and Erlangen University Hospital","place":["Erlangen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative: determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/apt.17622","article-title":"Review article: translating STRIDE-II into clinical reality\u2009\u2013\u2009opportunities and challenges","volume":"58","author":"Dignass","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"B3","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2024-334395","article-title":"British Society of gastroenterology guidelines on inflammatory bowel disease in adults: 2025","volume":"74","author":"Moran","year":"2025","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA Clinical practice guideline on the role of biomarkers for the management of ulcerative colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.32592\/TJT.2024.1.3.16","article-title":"Telemedicine\u2019s role in shaping the future of healthcare delivery: a systematic review","volume":"1","author":"Naseri","year":"2024","journal-title":"J Telemed Telecare"},{"key":"B6","doi-asserted-by":"publisher","first-page":"100843","DOI":"10.1016\/j.landig.2024.12.007","article-title":"Efficacy of digital health technologies in the management of inflammatory bowel disease: an umbrella review","volume":"7","author":"Gasparetto","year":"2025","journal-title":"Lancet Digit Health"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/ecco-jcc\/jjad075","article-title":"Management of inflammatory bowel disease using eHealth technologies: a systematic review and meta-analysis","volume":"17","author":"Kuriakose Kuzhiyanjal","year":"2023","journal-title":"J Crohns Colitis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e70186","DOI":"10.1002\/hsr2.70186","article-title":"Designing the essential informational needs of a smartphone application for self-management of patients with inflammatory bowel disease","volume":"7","author":"Asadi","year":"2024","journal-title":"Health Sci Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e69093","DOI":"10.2196\/69093","article-title":"Development of an mHealth solution for tailored communication between patients with inflammatory bowel disease and health care professionals: participatory design study","volume":"17","author":"Fallesen","year":"2025","journal-title":"J Particip Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.34172\/mejdd.2024.394","article-title":"Developing mobile health applications for inflammatory bowel disease: a systematic review of features and technologies","volume":"16","author":"Akbarian","year":"2024","journal-title":"Middle East J Dig Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e64471","DOI":"10.2196\/64471","article-title":"Mhealth use, preferences, barriers, and eHealth literacy among patients with inflammatory bowel disease: survey study","volume":"12","author":"Kretzschmar","year":"2025","journal-title":"JMIR Hum Factors"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e31102","DOI":"10.2196\/31102","article-title":"Review and analysis of German mobile apps for inflammatory bowel disease management using the Mobile application rating scale: systematic search in app stores and content analysis","volume":"10","author":"Gerner","year":"2022","journal-title":"JMIR Mhealth Uhealth"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20552076231203664","DOI":"10.1177\/20552076231203664","article-title":"User testing to modify the MyHealthyGut digital health application for inflammatory bowel disease","volume":"9","author":"Erlich","year":"2023","journal-title":"Digit Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1186\/s12913-025-13323-2","article-title":"User-needs based app for patients with inflammatory bowel disease: development and usability study","volume":"25","author":"Park","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"B15","year":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"Von Elm","year":"2007","journal-title":"PLoS Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e57771","DOI":"10.2196\/57771","article-title":"German Version of the telehealth usability questionnaire and derived short questionnaires for usability and perceived usefulness in health care assessment in telehealth and digital therapeutics: instrument validation study","volume":"11","author":"Zimmermann","year":"2024","journal-title":"JMIR Hum Factors"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5195\/ijt.2016.6196","article-title":"Development of the telehealth usability questionnaire (TUQ)","volume":"8","author":"Parmanto","year":"2016","journal-title":"Int J Telerehabil"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1111\/hex.13577","article-title":"The ultimate question? Evaluating the use of net promoter score in healthcare: a systematic review","volume":"25","author":"Adams","year":"2022","journal-title":"Health Expect"},{"key":"B20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/jcag\/gwae029","article-title":"Acceptability, feasibility, and impact of the MyGut digital health platform in the monitoring and management of inflammatory bowel disease","volume":"7","author":"Zhen","year":"2024","journal-title":"J Can Assoc Gastroenterol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1587765","DOI":"10.3389\/fdgth.2025.1587765","article-title":"iACT4IBD: a randomised controlled trial of a brief online intervention based on acceptance and commitment therapy to improve wellbeing for adults with inflammatory bowel disease","volume":"7","author":"Lin","year":"2025","journal-title":"Front Digit Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1726618","DOI":"10.3389\/fphar.2025.1726618","article-title":"Patients\u2019 experiences and practices of medication literacy in inflammatory bowel disease: a qualitative study","volume":"16","author":"Pan","year":"2026","journal-title":"Front Pharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e154556","DOI":"10.5812\/jjcdc-154556","article-title":"Design and evaluation of a mobile health application for self-care of diabetic retinopathy patients: participatory design study","volume":"14","author":"Valizadeh Laktarashi","year":"2025","journal-title":"Jundishapur J Chronic Dis Care"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-026-05001-2","article-title":"Evaluation of fatty liver disease self-care applications: a systematic review and evaluation of apps using the mobile application rating scale (MARS)","author":"Mohammadzadeh","year":"2026","journal-title":"BMC Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijmedinf.2019.03.018","article-title":"Methods of usability testing in the development of eHealth applications: a scoping review","volume":"126","author":"Maramba","year":"2019","journal-title":"Int J Med Inform"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.2196\/resprot.6452","article-title":"Opening the black box of electronic health: collecting, analyzing, and interpreting log data","volume":"6","author":"Sieverink","year":"2017","journal-title":"JMIR Res Protoc"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1957062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:35:05Z","timestamp":1788845705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2026.1957062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":26,"alternative-id":["10.3389\/fdgth.2026.1957062"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2026.1957062","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1957062"}}